Open Access
Open access
Journal of Nanobiotechnology, volume 19, issue 1, publication number 354

Nanomedicine for increasing the oral bioavailability of cancer treatments

Parodi Alessandro 1, 2
Buzaeva Polina 1
Nigovora Daria 1
Baldin Alexey 3
Chulanov Vladimir 2, 4, 5
Savvateeva Lyudmila V. 1
Zamyatnin Andrey A. 1, 2, 3, 6
Publication typeJournal Article
Publication date2021-10-30
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor10.2
ISSN14773155
Medicine (miscellaneous)
Pharmaceutical Science
Molecular Medicine
Applied Microbiology and Biotechnology
Bioengineering
Biomedical Engineering
Abstract

Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent decades, the fields of material science and nanomedicine have generated several delivery platforms with high potential for overcoming multiple barriers associated to oral administration. This review describes the properties of several nanodelivery systems that improve the bioavailability of orally administered therapeutics, highlighting their advantages and disadvantages in generating successful anticancer oral nanomedicines.

Graphical Abstract

Citations by journals

1
2
3
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 3, 7.69%
International Journal of Molecular Sciences
3 publications, 7.69%
Pharmaceutics
Pharmaceutics, 2, 5.13%
Pharmaceutics
2 publications, 5.13%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 2, 5.13%
Journal of Nanobiotechnology
2 publications, 5.13%
Journal of Controlled Release
Journal of Controlled Release, 2, 5.13%
Journal of Controlled Release
2 publications, 5.13%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 2, 5.13%
International Journal of Biological Macromolecules
2 publications, 5.13%
International Journal of Nanomedicine
International Journal of Nanomedicine, 2, 5.13%
International Journal of Nanomedicine
2 publications, 5.13%
Nanoscale Advances
Nanoscale Advances, 1, 2.56%
Nanoscale Advances
1 publication, 2.56%
Materials
Materials, 1, 2.56%
Materials
1 publication, 2.56%
Gels
Gels, 1, 2.56%
Gels
1 publication, 2.56%
Polymers
Polymers, 1, 2.56%
Polymers
1 publication, 2.56%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 1, 2.56%
Frontiers in Bioengineering and Biotechnology
1 publication, 2.56%
Frontiers in Chemistry
Frontiers in Chemistry, 1, 2.56%
Frontiers in Chemistry
1 publication, 2.56%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 1, 2.56%
Frontiers in Cell and Developmental Biology
1 publication, 2.56%
Journal of Industrial and Engineering Chemistry, 1, 2.56%
Journal of Industrial and Engineering Chemistry
1 publication, 2.56%
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 1, 2.56%
Acta Pharmaceutica Sinica B
1 publication, 2.56%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 1, 2.56%
Journal of Drug Delivery Science and Technology
1 publication, 2.56%
Biomedical Technology
Biomedical Technology, 1, 2.56%
Biomedical Technology
1 publication, 2.56%
Advanced healthcare materials
Advanced healthcare materials, 1, 2.56%
Advanced healthcare materials
1 publication, 2.56%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 1, 2.56%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
1 publication, 2.56%
Cancers
Cancers, 1, 2.56%
Cancers
1 publication, 2.56%
Expert Opinion on Drug Delivery
Expert Opinion on Drug Delivery, 1, 2.56%
Expert Opinion on Drug Delivery
1 publication, 2.56%
Asian Journal of Pharmaceutical Sciences, 1, 2.56%
Asian Journal of Pharmaceutical Sciences
1 publication, 2.56%
Medical Review
Medical Review, 1, 2.56%
Medical Review
1 publication, 2.56%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 1, 2.56%
Biomedicine and Pharmacotherapy
1 publication, 2.56%
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids, 1, 2.56%
Molecular Therapy - Nucleic Acids
1 publication, 2.56%
Toxicology Research
Toxicology Research, 1, 2.56%
Toxicology Research
1 publication, 2.56%
Materials Advances
Materials Advances, 1, 2.56%
Materials Advances
1 publication, 2.56%
Materials and Design
Materials and Design, 1, 2.56%
Materials and Design
1 publication, 2.56%
Journal of Pharmaceutical Analysis, 1, 2.56%
Journal of Pharmaceutical Analysis
1 publication, 2.56%
1
2
3

Citations by publishers

2
4
6
8
10
12
Elsevier
Elsevier, 11, 28.21%
Elsevier
11 publications, 28.21%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 23.08%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 23.08%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 3, 7.69%
Royal Society of Chemistry (RSC)
3 publications, 7.69%
Frontiers Media S.A.
Frontiers Media S.A., 3, 7.69%
Frontiers Media S.A.
3 publications, 7.69%
Wiley
Wiley, 3, 7.69%
Wiley
3 publications, 7.69%
Springer Nature
Springer Nature, 2, 5.13%
Springer Nature
2 publications, 5.13%
Dove Medical Press
Dove Medical Press, 2, 5.13%
Dove Medical Press
2 publications, 5.13%
Korean Society of Industrial Engineering Chemistry, 1, 2.56%
Korean Society of Industrial Engineering Chemistry
1 publication, 2.56%
Taylor & Francis
Taylor & Francis, 1, 2.56%
Taylor & Francis
1 publication, 2.56%
Shenyang Pharmaceutical University, 1, 2.56%
Shenyang Pharmaceutical University
1 publication, 2.56%
Walter de Gruyter
Walter de Gruyter, 1, 2.56%
Walter de Gruyter
1 publication, 2.56%
Xi'an Jiaotong University, 1, 2.56%
Xi'an Jiaotong University
1 publication, 2.56%
2
4
6
8
10
12
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Parodi A. et al. Nanomedicine for increasing the oral bioavailability of cancer treatments // Journal of Nanobiotechnology. 2021. Vol. 19. No. 1. 354
GOST all authors (up to 50) Copy
Parodi A., Buzaeva P., Nigovora D., Baldin A., Kostyushev D., Chulanov V., Savvateeva L. V., Zamyatnin A. A. Nanomedicine for increasing the oral bioavailability of cancer treatments // Journal of Nanobiotechnology. 2021. Vol. 19. No. 1. 354
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1186/s12951-021-01100-2
UR - https://doi.org/10.1186%2Fs12951-021-01100-2
TI - Nanomedicine for increasing the oral bioavailability of cancer treatments
T2 - Journal of Nanobiotechnology
AU - Buzaeva, Polina
AU - Nigovora, Daria
AU - Kostyushev, Dmitry
AU - Chulanov, Vladimir
AU - Savvateeva, Lyudmila V.
AU - Parodi, Alessandro
AU - Baldin, Alexey
AU - Zamyatnin, Andrey A.
PY - 2021
DA - 2021/10/30 00:00:00
PB - Springer Nature
IS - 1
VL - 19
PMID - 34717658
SN - 1477-3155
ER -
BibTex
Cite this
BibTex Copy
@article{2021_Parodi,
author = {Polina Buzaeva and Daria Nigovora and Dmitry Kostyushev and Vladimir Chulanov and Lyudmila V. Savvateeva and Alessandro Parodi and Alexey Baldin and Andrey A. Zamyatnin},
title = {Nanomedicine for increasing the oral bioavailability of cancer treatments},
journal = {Journal of Nanobiotechnology},
year = {2021},
volume = {19},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1186%2Fs12951-021-01100-2},
number = {1},
doi = {10.1186/s12951-021-01100-2}
}
Found error?